Medtronic has launched its heart failure management service in the U.S. It combines data from its implantable cardiac devices with remote patient monitoring to help physicians act early to ward off heart failure events in at-risk patients.
Medtronic will add a heart failure implant and pipeline products in its $1.1 billion acquisition of HeartWare. The deal will accelerate the development of HeartWare's products and round out Medtronic's Cardiac Rhythm & Heart Failure division.
The FDA said it acted properly by accepting late patient injury reports from a Medtronic study that showed problems with its Infuse bone graft, adding that the information provided by the devicemaker was "consistent" with data the regulatory agency already had.
Medtronic is picking up a whole line of chronic disease management programs to market from a new partnership with Canary Health. The devices giant anticipates that the programs, which encourage and direct patients toward better self-care, will be reimbursable--which can be a tough hurdle for software-based approaches to disease.
Medtronic reported pivotal data for its hybrid closed-loop system at the American Diabetes Association conference in New Orleans, LA, over the weekend. The data show that the hybrid closed-loop system helped to decrease A1c levels as well as reduce variability in sensor glucose values for 124 patients with Type 1 diabetes.
A federal judge delivered a win for Medtronic in its $1.4 billion lawsuit against the Internal Revenue Service over how much of its profits should be taxed federally and how much should face lower taxes in Puerto Rico.
Startup Glooko is working to make the data from all sorts of diabetes devices--from standard blood glucose monitors to insulin pumps to continuous blood glucose monitors--available for analysis after the fact to encourage better, more informed decisions over time by patients and physicians.
Intuitive Surgical has enjoyed a sizable head start in the robotic surgery arena. But Medtronic is gaining momentum, having partnered in May with small-cap robotics player Mazor, and now detailing plans for its internally developed robotic surgery program.
Medtronic is just a few days away from detailing pivotal data for its hybrid Closed Loop System at the American Diabetes Association conference. That's expected to be followed by a PMA submission in June, with an approval anticipated to follow in the spring.
Medtronic will report pivotal data for its Hybrid Closed Loop system for Type 1 diabetes on June 12 at the American Diabetes Association conference in New Orleans, LA.